Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion type Assertion NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_head.
- NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion wasGeneratedBy ECO_0000203 NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_provenance.
- NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion wasDerivedFrom befree-20150227 NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_provenance.
- NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion SIO_000772 19171333 NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_provenance.
- NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion evidence source_evidence_literature NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_provenance.
- NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_assertion description "[To determine whether endometrial expression of the integrin alpha(v)beta(3) vitronectin can predict which endometriosis patient subgroup will benefit from pre-IVF cycle prolonged GnRH agonist (GnRHa) therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775825.RAYrLDnYGTzkfX_NGxCszBx_Sb4GHlRo7WixGFd_eLgvI130_provenance.